Table 3.

Characteristics and Outcomes of Patients With a Permanent Stent Occlusion.

Patient	Remarks	Patient reported outcome measures
Female patient	Stent	CIVIQ-20
32 years old	• Wallstent	total score: 49
PTS, left limb	• Placed across the inguinal ligament
	• Good inflow DFV and FV.
	Hematological	SF-36
	• Heterozygous MTHFR mutation	mental component summary: 55.2
	• Anticoagulants: VKA	Physical component summary: 40.3
	Comorbidity: Multiple VTE, complicated pregnancy, miscarriage.	Follow-up
	Cause: Cessation of anticoagulant therapy because of blood loss during pregnancy	6.7 years
Female patient	Stent	CIVIQ-20
63 years old	• Wallstent, smart and SinusXL stents.	total score: 67
PTS, bilateral	• Both sides placed above the inguinal ligament
	• Impaired inflow of left DFV and FV.
	Good inflow of the right DFV and FV.
	Hematological	SF-36
	• Antiphospholipid syndrome	mental component summary: 49.7
	• Anticoagulants: VKA	Physical component summary: 32.2
	Comorbidity: Multiple VTE, alopecia androgenica, hirsutism, monoclonal gammopathy.	Follow-up
	Cause: Pre-existent poor stent inflow	12.7 years
Male patient	Stent	CIVIQ-20
49 years old	• Wallstent	total score: 88
PTS, left limb	• Placed across the inguinal ligament
	• Poor inflow of the DFV, impaired inflow of the FV
	Hematological	SF-36
	• Thrombophilia not tested.	mental component summary: 24.2
	• Anticoagulants: Dual antiplatelet and VKA.	Physical component summary: 32.6
	Comorbidity: Former addiction to intravenous drugs, myocardial infarct, endocarditis, osteomyelitis, thoracic empyema, femoral fractures treated by surgical reposition and fixation.	Follow-up7.8 years
	Cause: Pre-existent poor stent inflow

Age and follow-up at time the questionnaire was filled out. PTS: post-thrombotic syndrome. VTE: venous thromboembolism. VKA: vitamin-K-antagonist; DFV = deep femoral vein; FV: femoral vein.